The Most Advanced Method of NAD and Glutathione Measuring
For Professional Laboratories
Measure from blood
Quantifies all four forms of NAD and both glutathione species from all biological samples.
Highest accuracy
Clinically validated accuracy, matching or exceeding mass spectrometry, for both research and diagnostic applications.
Unprecedented speed
With NADMED CE-marked kits, the microplate-based enzymatic assay can be completed in a couple of hours.
Substantial savings
NADMED method is highly scalable, providing considerable savings in time and money.
WHAT IS NADMED METHOD?
WHY MEASURE NADS?
Is NAD⁺ boosting always beneficial?
Products & Services
Kits: CE-marked and RUO for blood & RUO for tissue/cell
Professional laboratory kits to measure REDOX metabolites from any sample type.
READ MORE
Laboratory Services
NADMED laboratory services for REDOX metabolite analysis and supplement purity testing.
READ MORE
NADMED vs. Other Methods
Science
The NADMED method is grounded in robust scientific research from the University of Helsinki. At its core is a proprietary extraction process that enables highly accurate measurement of all four forms of NAD and two forms of glutathione (key redox metabolites) with even greater precision than mass spectrometry.
The method relies on precise colorimetric quantification, applicable to samples from blood, tissue, or cells.
What sets the NADMED method apart is its ability to measure each metabolite individually, something no other method currently offers.
Trusted by
Over
companies / organisations
In more than
countries
Conducted already
NADMED measurements worldwide
“We have been in contact with NADMED since December 2020. First starting as a research collaboration, we enjoyed the fruitful scientific discussion, cooperative project planning, and data quality. After transitioning to a commercial service, we have been impressed and very satisfied with their great customer service and accessibility, prompt processing of samples, and quality of delivered data. We continue to use NADMED services as part of our clinical trial efforts and are looking forward to further scientific exchange and successful project collaboration.”
Christian Dölle, Neuro-SysMed researcher, University of Bergen and Haukeland University Hospital
“We had a great experience working with NADMED. Together with the CRO that execute our mouse study, they took over the handling of shipments and provided clear instructions on how samples should be stored and handled. NADMED was very helpful in every step of the process. The data was delivered well before the anticipated deadline and was of very high quality. I’m sure we will also run our next study with NADMED.”
Tim Peterson, CEO, BIOIO Tech
”Nicotinamide adenine dinucleotide (NAD) is essential for cellular energy metabolism, especially in the mitochondria, where it aids in producing ATP, the cell’s primary energy unit. Increasing NAD+ levels and improving the NAD+/NADH ratio through NAD+ precursors has shown promising results in preclinical models of aging and mitochondrial disorders. By measuring NAD+/NADH levels in patients, healthcare providers can tailor supplement prescriptions to those who need them, ensuring personalized and effective therapy while minimizing potential harm. Exact measurements are therefore important, which is why Ganzimmun has chosen to use a precise, yet uncomplicated, and most importantly, CE-marked blood kit from NADMED.”
Dr. Ksenija Vujačić-Mirski, Project Leader for Mitochondrial Diagnostics, GANZIMMUN Diagnostics GmbH
”We have partnered with NADMED Laboratories for the past two years, during which NADMED analyzed critical clinical trial samples for us. Our experience with NADMED’s sample handling, analysis, and data interpretation has been exemplary. NADMED colleagues’ expertise in NAD-related science has been exceptional and highly valuable to our drug development efforts. Their service has always been friendly and prompt, and the personnel at NADMED have consistently shown a high level of cooperation and remarkable flexibility when needed. Implementing NAD-metabolite measurements in our biomarker studies has contributed significantly to our ongoing efforts to bring treatment options to patients.”
Karen S Ho, Vice President, Clene Nanomedicine
News
NADMED Secures €3.5M to Accelerate International Sales Expansion
The investment round was led by Finnish science-based startup investor Nordic Science Investments (NSI). Additional...
Research Calls for Controlled Dosing of NAD-boosters
A study involving a healthy population of 1162 individuals revealed that persistent high niacin intake, whether...
High NAD amounts slow growth of proliferative cancer cells
In a recent study, researchers found that high NAD(H)+ amounts slow down the growth of highly proliferative cancer...
Yes, I want to subscribe to a newsletter.